2. Search Result
Search Result
Results for "

TCD

" in MedChemExpress (MCE) Product Catalog:

5

Inhibitors & Agonists

1

Inhibitory Antibodies

1

Natural
Products

1

Antibodies

1

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-P99904
    Siplizumab

    MEDI-507; TCD601

    		 CD2 Inflammation/Immunology Cancer
    Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody against CD2. Siplizumab depletes T cells, decreases T cell activation, inhibites T cell proliferation and enriches naïve and bona fide regulatory T cells .
    Siplizumab
  • HY-101144
    RSM-932A

    TCD-717

    		 Choline Kinase Cancer
    RSM-932A (TCD-717) is a specific ChoKα inhibitor with IC50s of 1 and 33 μM for human recombinant ChoKα and ChoKβ enzymes, respectively. RSM-932A acts as the “first in humans” compound targeting ChoKα. RSM-932A is potent in vitro anti-proliferative and in vivo anti-tumoral activity against human xenografts in mice, showing high efficacy with low toxicity profiles .
    RSM-932A
  • HY-N10685
    3,7,25-Trihydroxycucurbita-5,23-dien-19-al

    TCD

    		 Drug Derivative Others Cancer
    3,7,25-Trihydroxycucurbita-5,23-dien-19-al (TCD) is a natural product, that can be isolated from the chloroform extract of the leaves of Momordica foetida .
    3,7,25-Trihydroxycucurbita-5,23-dien-19-al
  • HY-RS02636
    CHM Human Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    CHM Human Pre-designed siRNA Set A contains three designed siRNAs for CHM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    CHM Human Pre-designed siRNA Set A
    CHM Human Pre-designed siRNA Set A
  • HY-101144R
    RSM-932A (Standard)

    TCD-717 (Standard)

    		 Choline Kinase Reference Standards Cancer
    RSM-932A (Standard) is the analytical standard of RSM-932A (HY-101144). This product is intended for research and analytical applications. RSM-932A (TCD-717) is a specific ChoKα inhibitor with IC50s of 1 and 33 μM for human recombinant ChoKα and ChoKβ enzymes, respectively. RSM-932A acts as the “first in humans” compound targeting ChoKα. RSM-932A is potent in vitro anti-proliferative and in vivo anti-tumoral activity against human xenografts in mice, showing high efficacy with low toxicity profiles .
    RSM-932A (Standard)

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: